What you need to know about the coronavirus right now

(Reuters) – Here’s what you need to know about the coronavirus right now:

Biden rejects Trump claim that vaccine is imminent

U.S. Democratic presidential candidate Joe Biden on Thursday bluntly contradicted President Donald Trump’s suggestion that a coronavirus vaccine may be only weeks away, warning Americans they cannot trust the president’s word.

“The idea that there’s going to be a vaccine and everything’s gonna be fine tomorrow – it’s just not rational,” Biden said during a CNN town hall in Moosic, Pennsylvania.

Trump again said on Wednesday that a vaccine for COVID-19 could be ready for distribution ahead of the Nov. 3 election.

Most health experts, including Robert Redfield, the director of the Centers for Disease Control and Prevention, have said a vaccine will likely not be widely available until mid-2021.

Israel imposes second lockdown

Israel will enter a second nationwide lockdown on Friday at the onset of the Jewish high-holiday season, forcing residents to stay mostly at home amid a resurgence in new coronavirus cases.

The country’s initial lockdown was imposed in late March and eased in May as new cases tapered off, reaching lows in the single digits.

But in the past week, new cases have reached daily highs of over 5,000, and Israeli leaders now acknowledge they lifted measures too soon.

The new lockdown will last three weeks and coincides with the start of the Jewish New Year, Rosh Hashana, traditionally a time for large family gatherings and group prayer.

UK COVID hospital admissions double every eight days

Britain’s health minister said that the novel coronavirus was accelerating across the country, with hospital admissions doubling every eight days, but he refused to say if another national lockdown would be imposed next month.

The United Kingdom has reported the fifth-highest number of deaths from COVID-19 in the world after the United States, Brazil, India and Mexico, according to data collected by Johns Hopkins University of Medicine.

COVID-19 cases started to rise again in Britain in September, with between 3,000 and 4,000 positive tests recorded daily in the last week. More than 10 million people are already in local lockdowns.

China reports highest new cases since Aug. 10

Mainland China reported 32 new COVID-19 cases on Thursday, marking the highest daily increase in more than a month and up sharply from nine cases reported a day earlier.

Although the latest increase still remains well below the peaks seen at the height of the outbreak in China early this year, it is the biggest since Aug. 10 and suggests continued COVID-19 risks stemming from overseas travelers coming into the country as the pandemic rages on in other parts of the world.

The National Health Commission said that all new cases were imported infections. Mainland China has not reported any local COVID-19 infections since mid-August.

Canada’s Ontario clamps down on parties

Canada’s most populous province will clamp down on social gatherings to prevent “reckless careless people” from spreading the coronavirus at illegal parties, Ontario Premier Doug Ford said on Thursday.

His warning came as the nation’s top medical officer said authorities could potentially lose the ability to manage the pandemic.

Indoor social events in Toronto, Canada’s biggest city – along with Ontario’s Peel and Ottawa regions – would be authorized to include no more than 10 people, down from a previous limit of 50, Ford said.

“This is a serious situation, folks. We will throw the book at you if you break the rules,” he told a news conference.

(Compiled by Linda Noakes; Editing by Hugh Lawson)

Global coronavirus cases surpass 30 million: Reuters tally

By Jane Wardell

(Reuters) – Global coronavirus cases exceeded 30 million on Thursday, according to a Reuters tally, with the pandemic showing no signs of slowing.

India was firmly in focus as the latest epicenter, although North and South America combined still accounted for almost half of the global cases.

Global new daily case numbers reached record levels in recent days and deaths neared 1 million as the international race to develop and market a vaccine heated up.

The official number of global coronavirus cases is now more than five times the number of severe influenza illnesses recorded annually, according to World Health Organization data.

Around the world, there have been almost 1 million deaths, considered a lagging indicator given the two-week incubation period of the virus. That has well exceeded the upper range of 290,000 to 650,000 annual deaths linked to influenza.

India this week became only the second country in the world, after the United States, to record more than 5 million cases. On Thursday, it reported another record daily rise in cases of almost 98,000.

The south Asian nation, the world’s second most populous country, has been reporting more new daily cases than the United States since mid-August and accounts for just over 16% of global known cases.

Reported deaths in India have been relatively low so far but are showing an uptick, and the country has recorded more than 1,000 deaths every day for the last two weeks.

The United States has about 20% of all global cases, although it has just 4% of the world’s population. Brazil, the third worst-hit country, accounts for roughly 15% of global cases.

It took 18 days for global cases to surge from 25 million to more than 30 million. It took 20 days for the world to go from 20 million to 25 million and 19 days to go from 15 million to 20 million.

The global rate of new daily cases is slowing, reflecting progress in constraining the disease in many countries, despite a few big surges.

Australia on Thursday reported its lowest single-day case rise since June as strict lockdown measures in its second largest city of Melbourne, the center of the country’s second wave, appeared to pay off.

Health experts stress that official data almost certainly under-reports both infections and deaths, particularly in countries with limited testing capacity.

The race to develop and bring to market a novel coronavirus vaccine has grown increasingly frenetic in recent weeks with about 200 candidates in development globally.

U.S. President Donald Trump has said his country could have a vaccine ready for distribution before the U.S. election on Nov. 3, while a Chinese health official this week said China may have a vaccine ready for public use as early as November.

While the trajectory of the coronavirus still falls far short of the 1918 Spanish flu, which infected an estimated 500 million people, killing at least 10% of them, experts worry the available data is underplaying the true impact of the pandemic.

(Reporting by Jane Wardell; editing by Robert Birsel and Lisa Shumaker)

U.S. CDC reports 196,277 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Thursday reported 6,613,331 cases of the new coronavirus, an increase of 41,464 cases from its previous count, and said the number of deaths had risen by 1,224 to 196,277.

The CDC’s tally of cases of the respiratory illness known as COVID-19, caused by the new coronavirus, was as of 4 p.m. ET on Sept. 16 versus its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting By Mrinalika Roy in Bengaluru; Editing by Aditya Soni)

U.S. CDC reports 195,053 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Wednesday reported 6,571,867 cases of the new coronavirus, an increase of 34,240 cases from its previous count, and said the number of deaths had risen by 961 to 195,053.

The CDC’s tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, was of 4 p.m. ET on Sept. 15 versus its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting by Dania Nadeem in Bengaluru; Editing by Krishna Chandra Eluri)

Lilly says antibody drug cuts COVID-19 hospitalization, may seek emergency use nod

By Deena Beasley

(Reuters) – Eli Lilly and Co on Wednesday said a single infusion of its experimental antibody treatment reduced the need for hospitalization and emergency room visits for clinical trial patients with moderate COVID-19.

The company said it will discuss the interim results, which have not yet been reviewed by outside experts, with global regulators. The New York Times reported that Lilly Chief Scientific Officer Daniel Skovronsky said the company would talk with the U.S. Food and Drug Administration about the possibility of an emergency use authorization.

The mid-stage study tested three different doses of LY-CoV555, a manufactured copy of a an antibody produced by a patient who recovered from COVID-19. Antibody treatments work by recognizing and locking onto foreign invaders to prevent infection of healthy cells.

Of the total 302 patients treated with the Lilly drug, five or 1.7%, had to be hospitalized or required an emergency room visit. That compared with 6% in the placebo group, Lilly said.

“These data are not a home run but … are among the most encouraging COVID treatment data we’ve seen, particularly given this is in mild-to-moderate outpatients where there has simply been no treatment progress until now,” Raymond James analyst Steven Seedhouse said in a research note.

Oddly, only the middle 2,800-milligram dose achieved the trial’s main goal of reducing the amount of virus detected in patients compared with a placebo 11 days after treatment. Lilly said most trial participants, including those given a placebo, had completely cleared the virus by day 11. Some analysts suggested that future studies may want to use an earlier time point than 11 days.

Most hospitalizations occurred in patients with underlying risk factors such as obesity or advanced age. Lilly said future study would focus on people in these higher-risk groups.

No drug-related serious adverse events or trial deaths were reported.

Lilly said the trial will enroll 800 patients with mild-to-moderate COVID-19, with the next segment testing LY-CoV555 in combination with a second Lilly antibody, LY-CoV016, which binds to a different area of the coronavirus.

The antibodies, given by intravenous infusion, are also being tested for preventing COVID-19 in nursing home residents and staff and for treating patients already hospitalized with COVID-19.

Several companies including Regeneron Pharmaceuticals Inc and Vir Biotechnology are also testing antibody treatments for COVID-19.

Lilly’s shares were up 1.3% to $152.

(Reporting by Deena Beasley in Los Angeles and Manas Mishra in Bengaluru; Editing by Shinjini Ganguli and Bill Berkrot)

Pandemic ‘hero’ Filipino nurses struggle to leave home

By Karen Lema and Clare Baldwin

MANILA (Reuters) – From across the Philippines, they gathered to pray by Zoom.

They were praying to be allowed to leave: To be allowed to take up nursing jobs in countries where the coronavirus is killing thousands in hospitals and care homes. In recent months, these care workers have taken to calling themselves “priso-nurses.”

With infections also surging in the Philippines, the government in April banned healthcare workers from leaving the country. They were needed, it said, to fight the pandemic at home.

But many of the nurses on the two-hour Zoom call on Aug. 20, organised by a union and attended by nearly 200 health workers both in the Philippines and abroad, were unwilling to work at home. They said they felt underpaid, unappreciated and unprotected.

Nurses have been leaving the Philippines for decades, encouraged by the government to join other workers who send back billions of dollars each year.

With COVID-19 sweeping the globalized economy, the Philippine ban squeezed a supply line that has sent hundreds of thousands of staff to hospitals in the United States, the Gulf and Britain, where some commentators have called the nurses “unsung heroes” of the pandemic.

The Philippines’ healthcare system is already short-handed. In Germany there are 430 doctors and nurses per 10,000 people, in the United States 337 and in Britain 254, International Labor Organization data shows.

The Philippines – where the coronavirus death rate is one of the highest in Southeast Asia – has 65.

The April ban has stopped more than 1,000 nurses from leaving the country. Of those, only 25 have applied to work in local hospitals, Health Secretary Francisco Duque III told journalists late last month. The Department of Health did not reply to a request for an updated figure.

The government has since partially eased the restrictions, but sometimes also tightens them, so nurses are still clamoring to get out.

On the Zoom call in August, someone played a recording of the Philippine national anthem. A Catholic priest prayed and a man with a soft voice crooned a song about passing off your burdens to God.

One nurse, 34-year-old April Glory, had already spent years away from her young son and had been about to leave again when the ban kicked in. Even before the pandemic, she told Reuters separately, she was better off in a war zone in the Middle East than at home.

Soon after she arrived in Yemen in 2011, a bullet pierced the wall of her private hospital, she said. Staff moved patients to safety.

Still, she said, “we were insured, we had free lodging so my salary was intact and I could send more to my family.” Abroad, there was no need to do any work outside her job description: “You are not expected to sweep the floor.”

SIMPLE MATH

It’s mainly money that drives the Filipinos abroad.

A nurse in the United States can earn as much as $5,000 per month; in the Middle East it’s $2,000 per month, tax free. In Germany, nurses can earn up to $2,800 per month, and get language training, labor organizers, recruiters and the Philippine government’s overseas employment agency say.

Even with its emergency hiring efforts, the Philippine Department of Health is only offering nurses a starting salary of $650 per month. It says it will pay another $10 per day as COVID-19 hazard allowance.

Private nurses sometimes make just $100 per month.

“I felt that I was not earning enough,” said Glory, explaining why she left. Her son, now 11, was a year and a half old at the time. “My mother told me: Better to leave now because my child will not really remember.”

Abroad, Glory’s shifts were a standard eight hours and she only looked after one or two patients at a time in intensive care. Working in Yemen and then Saudi Arabia, she said she bought a house and a car.

Nurses have recently left faster than they are trained. Last year, 12,083 new nurses graduated in the Philippines. That same year, 16,711 signed contracts to go abroad, data from the Commission on Higher Education and the Philippine Overseas Employment Administration shows. Those renewing foreign contracts are counted separately. So far this year there have been 46,000 such renewals.

The Philippine government wasn’t able to provide figures for the total number of nurses overseas, or say which countries they are working in.

Filipinos are the biggest group of foreign nurses in the United States. In 2018, there were 348,000, an analysis of U.S. government data by Washington D.C.-based think tank Migration Policy Institute showed. Even with the pandemic, another 3,260 Filipinos have passed the U.S. nurse licensing exam this year.

A report to Britain’s House of Commons Library in May said more than 15,000 of the National Health Service nursing jobs held by foreigners went to Filipinos – nearly a third of the total and more than any other nationality. The NHS employs a further 6,600 Filipinos in other healthcare jobs.

Labor brokers say that, besides the UK and US, Filipino nurses are sought-after in Germany, Saudi Arabia, the United Arab Emirates and Singapore.

36-HOUR SHIFTS

Nine months into the pandemic in the Philippines, reported coronavirus infections in the Philippines have soared to around 270,000. Not all hospitals allow family members to visit, so nurses must feed and clean patients as well as giving health care, said Filipino Nurses United President Maristela Abenojar.

Some nurses are working up to 36-hour shifts because relief staff are calling in sick or not reporting for duty, she said, and sometimes nurses are issued just one set of protective gear per shift. Nurses can’t get tested regularly and if they get sick, there aren’t always hospital beds reserved for them, she said.

At least 56 healthcare workers have died in the Philippines, Department of Health data shows.

“It seems they don’t really value our contributions,” said Jordan Jugo, who works at a private hospital in the Philippines. “It hurts.” He had a contract to work in Britain, but the ban prevented him from leaving.

He said he could sometimes only eat two meals a day and could no longer support his siblings.

The Philippine Department of Health said its healthcare workers work long hours and “it is natural for them to feel tired and overwhelmed with their immense responsibilities.” It said it had arranged for “substitution teams” in some areas.

It said hospitals should provide sufficient protective gear and that healthcare workers should not go on duty without it. Healthcare workers should be prioritized for regular COVID-19 testing, it said, and the Department would ensure there are enough beds for everyone.

Health Secretary Duque has said previously that the government was appealing to the nurses’ “sense of nation, sense of people and sense of service.”

“I DON’T WANT TO BE A HERO”

Foreign countries have gone all-out to show Filipino nurses they are valued.

Saudi Arabia sent chartered planes to help them return to work, and only partly filled them so the nurses could maintain social distance.

British ambassador to the Philippines Daniel Pruce went on an 11-minute segment on Philippine television to praise the “incredible commitment and dedication” of Filipino healthcare workers in Britain.

When nurse Aileen Amoncio, 36, got trapped by a lockdown and then the travel ban during a vacation to the Philippines in March, Britain’s NHS granted her a special “COVID leave” and kept paying her, she said. The NHS said staff stuck abroad due to COVID-19 could qualify for such leave.

Amoncio got out of the Philippines in June, after the government eased the ban slightly.

Working at an NHS neurological rehabilitation hospital in the UK, she said she sympathized with the nurses back home, where she once handled as many as 80 patients on a surgical ward at a small hospital. Now she looks after no more than 10 at a time.

Not only are the pay and conditions better in Britain, she said, but she also hopes her daughter will one day be able to join her and get free treatment on the NHS. The hearing implant she needs would cost $20,000 in the Philippines.

“I’ve served my country already,” said Amoncio. “I don’t want to be a hero again. I am looking out for the future of my children.”

On the Zoom call, Labor Secretary Silvestre Bello III dialed in with an update: Some of those who had existing contracts could leave, he announced. Cheers went up.

Nurse Glory was one of them. She wept.

“I hope the government will not take it against us that we are leaving,” she said. “We are looking forward to helping the government with this fight in other ways. When we are able, when we’ve risen out of poverty, we will.”

Hours later, on the pavement outside the airport, she quickly hugged her son, then raced to board her flight in case the government changed its mind.

(Additional reporting by Eloisa Lopez; Edited by Matthew Tostevin and Sara Ledwith)

Thousands of Oregon evacuees shelter from wildfires as U.S. disaster declared

By Deborah Bloom and Brad Brooks

PORTLAND, Ore. (Reuters) – Thousands of evacuees displaced by deadly wildfires in Oregon settled into a second week of life in shelters and car camping on Tuesday as fire crews battled on, and search teams scoured the ruins of incinerated homes for the missing.

With state resources stretched to their limit, President Donald Trump approved a request from Oregon’s governor for a federal disaster declaration, bolstering U.S. government assistance for emergency response and relief efforts.

Dozens of fires have charred some 4.5 million acres (1.8 million hectares) of tinder-dry brush, grass and woodlands in Oregon, California and Washington state since August, ravaging several small towns, destroying thousands of homes and killing at least 34 people.

Eight deaths have been confirmed during the past week in Oregon, which became the latest and most concentrated hot spot in a larger summer outbreak of fires across the entire western United States. The Pacific Northwest was hardest hit.

The conflagrations, which officials and scientists have described as unprecedented in scope and ferocity, have also filled the region’s skies with smoke and soot, compounding a public health crisis already posed by the coronavirus pandemic.

Satellite images showed high-altitude plumes of smoke from the fires drifting as far east as New York City and Washington, D.C., carried aloft by the jet stream.

The fires roared to life in California in mid-August, and erupted across Oregon and Washington around Labor Day last week, many of them sparked by catastrophic lightning storms and stoked by record-breaking heat waves and bouts of howling winds.

Weather conditions improved early this week, enabling firefighters to begin to make headway in efforts to contain and tamp down the blazes.

The California Department of Forestry and Fire Protection (CalFire) said 16,600 firefighters were still battling 25 major fires on Tuesday, after achieving full containment around the perimeter of other large blazes.

Firefighters in the San Gabriel Mountains just north of Los Angeles waged an all-out campaign to save the famed Mount Wilson Observatory and an adjacent complex of broadcast transmission towers from flames that crept to within 500 feet of the site.

RECORD ACREAGE LOST

At least 25 people have perished in California wildfires over the past four weeks, while more than 4,200 homes and other buildings have gone up in smoke, CalFire reported. Nearly 3 million acres (1.2 million hectares) in California alone have burned – more than in any single year in its history – and five of the 20 largest wildfires on record in the state have occurred during that time-frame.

One wildfire fatality has been confirmed in Washington state, where some 400 structures have been lost. Roughly 1 million acres (400,000 hectares) have been blackened in Oregon, double the state’s annual average over the past decade.

At the height of the crisis there, some 500,000 residents – at least 10% of the state’s population – were under some form of evacuation alert, many forced to flee their homes as swiftly advancing flames closed in on their neighborhoods. More than 1,700 structures, most of them dwellings, have been incinerated

At last count, some 16 people reported missing remained unaccounted for in Oregon, emergency management officials said. Last week, authorities said they were bracing for possible mass casualties as search teams began combing wreckage of homes destroyed during chaotic evacuations.

In the fire-stricken southwestern Oregon town of Phoenix, uprooted families, many with young children, were sleeping in their cars, huddling at a civic center or in churches, City Council member Sarah Westover said.

“It’s much more difficult to follow the COVID restrictions given the environment,” Westover said.

Marcus Welch, a food service director and youth soccer coach in Phoenix, said he was helping a group of high school students whose homes were spared to run a donation center set up to assist evacuees from a mobile-home park reduced to ash.

“Every day, I hear a sad story. Every day, I hear a family displaced. People are crying because high school kids are giving them food, water. … It’s been a total blessing,” Welch said. “Some people, they lost everything, so we encourage them to take everything they can.”

Westover said her community was in grief, while fearing a flareup might force them to flee again. Her house in Phoenix was spared, but others nearby were leveled.

“It’s like it cherry-picked – it burned down a house, then skipped two, then burned down another. I guess that’s the way they kind of work with the embers flying around,” Westover said.

Rhonda and Chuck Johnston, of Gates, Oregon, described celebrating their 32nd wedding anniversary outside their RV playing card games and eating barbecued chicken in the parking lot of a fairgrounds after a hasty evacuation.

“This is something you never think you’re going to go through,” Rhonda Johnston said. “We grabbed a couple days’ worth of clothes, pills, and two cars full of pictures and two dogs and a cat and our daughter.”

(Reporting by Gabriella Borter, Deborah Bloom, Shannon Stapleton and Adrees Latif; Writing by Will Dunham and Steve Gorman; Editing by Jonathan Oatis, Peter Cooney & Shri Navaratnam)

U.S. COVID-19 death analysis shows greater toll on Black, Hispanic youth: CDC

(Reuters) – A disproportionate percentage of U.S. COVID-19 deaths have been recorded among Black and Hispanic people younger than 21, according to a U.S. study, a reflection of the racial and ethnic make-up of essential workers who have more exposure to COVID-19.

The U.S. Centers for Disease Control and Prevention (CDC) reported that from Feb. 12 through July 31, there were 121 deaths among people younger than the age of 21 in 27 states.

Hispanic, Black, and non-Hispanic American Indian/Alaskan Native people accounted for about 75% of the deaths in that age group, even though they represent 41% of the U.S. population aged under 21.

The researchers looked at data from 47 of 50 states. Among the 121 deaths, 63% were male, 45% were Hispanic and 29% were Black.

Deaths among children younger than one accounted for 10% of the total, 20% of the deaths were among one-to-nine-year olds, while those aged between 10 and 20 years accounted for the rest.

A quarter of the 121 deaths were in previously healthy individuals with no reported underlying medical condition, while 75% had at least one underlying medical condition, including asthma.

The researchers said children from racial and ethnic minority groups, whose parents were likely to be essential workers, could also be over represented because of crowded living conditions, food and housing insecurity, wealth and educational gaps and racial discrimination.

The study appeared in the CDC’s Morbidity and Mortality Weekly Report.

The findings of this study could be limited by incomplete testing and delays in reporting COVID-19-associated deaths, among other things, the researchers said.

(Reporting by Vishwadha Chander in Bengaluru; Editing by Aditya Soni)

U.S. CDC reports 194,092 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday reported 6,537,627 cases of the new coronavirus, an increase of 34,597 cases from its previous count, and said the number of deaths had risen by 387 to 194,092.

The CDC’s tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, is as of 4 p.m. ET on Sept. 14 compared with its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting By Mrinalika Roy in Bengaluru; Editing by Vinay Dwivedi)

Exclusive: AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek – sources

By Julie Steenhuysen and Marisa Taylor

CHICAGO (Reuters) – AstraZeneca’s COVID-19 vaccine trial remains on hold in the United States pending a U.S. investigation into a serious side effect in Britain even as other trials of the vaccine resume, sources familiar with the details told Reuters.

AstraZeneca on Saturday said it had restarted its trial in Britain after regulators completed their review of a serious side effect in one trial participant there.

This was the first indication that the U.S. trial will remain on hold until the U.S. Food and Drug Administration and a safety panel investigate the case.

Enrollment in the company’s global trials of the vaccine, which it is developing with researchers at Oxford University, was put on pause on Sept. 6.

Sources told Reuters that enrollment of new patients and other trial procedures for the pivotal U.S. trial were being rescheduled until at least midweek and that it was not clear how long it would take for the FDA to complete its probe.

Governments around the world are desperate for a vaccine to help end the pandemic, which has caused more than 900,000 deaths and global economic turmoil. The World Health Organization (WHO) had flagged AstraZeneca’s as the most promising. A prolonged delay in the U.S. trial could slow access to the vaccine in the United States.

The British adverse event involved a study patient thought to be suffering a rare spinal inflammatory disorder called transverse myelitis.

An AstraZeneca spokeswoman declined to comment on when the U.S. trial would resume. She said in an email the company “will continue to work with health authorities across the world, including the FDA, and be guided as to when other clinical trials can resume.”

The status of the South African and Indian trials remains unknown, but the trial in Brazil has also restarted. The company has not commented on timing of resumption in other parts of the world besides Britain.

FDA did not immediately respond to a request for comment.

(Reporting by Julie Steenhuysen and Marisa Taylor; Editing by Peter Henderson and Cynthia Osterman)